Romiplostim prevents chemotherapy-induced thrombocytopenia or low platelet count, reducing bleeding risks in cancer patients ...
The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results